Incidence and outcome of uveitic glaucoma in eyes with intermediate, posterior or panuveitis followed up to 10 years after randomization to fluocinolone acetonide implant or systemic therapy.

Podobne zapisy

• Cost-Effectiveness of Fluocinolone Acetonide Implant Versus Systemic Therapy for Non-infectious Intermediate, Posterior and Panuveitis
  od: Sugar, Elizabeth A., i wsp.
  Wydane: (2014)
• Randomized Comparison of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Implant for Intermediate, Posterior and Panuveitis: The Multicenter Uveitis Steroid Treatment Trial
  od: Kempen, John H., i wsp.
  Wydane: (2011)
• Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis
  od: Kempen, John H., i wsp.
  Wydane: (2017)
• Proof of Concept for Combined Insertion of Fluocinolone Acetonide and Glaucoma Drainage Implants for Eyes with Uveitis and Glaucoma
  od: Ansari, Husam, i wsp.
  Wydane: (2010)
• Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior or Panuveitis: 54 month results of The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study
  od: Kempen, John H., i wsp.
  Wydane: (2015)